Annual ROE
-28.59%
+20.82%+42.14%
31 December 2023
Summary:
Protagonist Therapeutics annual return on equity is currently -28.59%, with the most recent change of +20.82% (+42.14%) on 31 December 2023. During the last 3 years, it has risen by +14.73% (+34.00%). PTGX annual ROE is now at all-time high.PTGX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
37.59%
-4.17%-9.99%
30 September 2024
Summary:
Protagonist Therapeutics quarterly return on equity is currently 37.59%, with the most recent change of -4.17% (-9.99%) on 30 September 2024. Over the past year, it has increased by +66.52% (+229.93%). PTGX quarterly ROE is now -20.71% below its all-time high of 47.41%, reached on 31 March 2024.PTGX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +229.9% |
| 3 y3 years | +34.0% | +191.4% |
| 5 y5 years | +64.3% | +146.1% |
PTGX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.1% | -20.7% | +166.8% |
| 5 y | 5 years | at high | +64.3% | -20.7% | +138.3% |
| alltime | all time | at high | +81.5% | -20.7% | +124.3% |
Protagonist Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 37.59%(-10.0%) |
| June 2024 | - | 41.76%(-11.9%) |
| Mar 2024 | - | 47.41%(-263.9%) |
| Dec 2023 | -28.59%(-42.1%) | -28.93%(-47.6%) |
| Sept 2023 | - | -55.24%(-0.6%) |
| June 2023 | - | -55.60%(-1.2%) |
| Mar 2023 | - | -56.29%(+17.4%) |
| Dec 2022 | -49.41%(+14.1%) | -47.93%(+6.3%) |
| Sept 2022 | - | -45.08%(+5.8%) |
| June 2022 | - | -42.61%(+7.7%) |
| Mar 2022 | - | -39.56%(-3.8%) |
| Dec 2021 | -43.32%(+17.7%) | -41.14%(+6.8%) |
| Sept 2021 | - | -38.52%(+16.6%) |
| June 2021 | - | -33.03%(-11.5%) |
| Mar 2021 | - | -37.32%(-14.3%) |
| Dec 2020 | -36.79% | -43.56%(-22.6%) |
| Sept 2020 | - | -56.31%(-24.9%) |
| June 2020 | - | -74.94%(-23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -98.27%(+20.4%) |
| Dec 2019 | -80.20%(+140.2%) | -81.60%(+14.7%) |
| Sept 2019 | - | -71.14%(+14.3%) |
| June 2019 | - | -62.23%(+53.5%) |
| Mar 2019 | - | -40.54%(+20.7%) |
| Dec 2018 | -33.39%(-5.9%) | -33.59%(+25.4%) |
| Sept 2018 | - | -26.79%(+2.3%) |
| June 2018 | - | -26.20%(-24.0%) |
| Mar 2018 | - | -34.47%(-26.7%) |
| Dec 2017 | -35.50%(-16.4%) | -47.02%(-26.8%) |
| Sept 2017 | - | -64.20%(+8.6%) |
| June 2017 | - | -59.09%(+4.8%) |
| Mar 2017 | - | -56.40%(-12.1%) |
| Dec 2016 | -42.46%(-72.6%) | -64.14%(-21.5%) |
| Sept 2016 | - | -81.68%(-44.8%) |
| June 2016 | - | -147.85%(+11.2%) |
| Mar 2016 | - | -132.91%(-14.2%) |
| Dec 2015 | -154.84%(+11.3%) | -154.84% |
| Dec 2014 | -139.18% | - |
FAQ
- What is Protagonist Therapeutics annual return on equity?
- What is the all time high annual ROE for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly ROE year-on-year change?
What is Protagonist Therapeutics annual return on equity?
The current annual ROE of PTGX is -28.59%
What is the all time high annual ROE for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual return on equity is -28.59%
What is Protagonist Therapeutics quarterly return on equity?
The current quarterly ROE of PTGX is 37.59%
What is the all time high quarterly ROE for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly return on equity is 47.41%
What is Protagonist Therapeutics quarterly ROE year-on-year change?
Over the past year, PTGX quarterly return on equity has changed by +66.52% (+229.93%)